Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Virginia Commonwealth University

Virginia Commonwealth University in Richmond, Virginia, United States is listed as a site for 997 registered clinical trials, 242 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 997
Ongoing 242

This page covers the site record Virginia Commonwealth University in Richmond, Virginia, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Virginia Commonwealth University, also sponsors trials.

Get the Virginia Commonwealth University report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 997 trials counted.

  • Phase 1 57 trials
  • Phase 1/2 41 trials
  • Phase 2 190 trials
  • Phase 2/3 17 trials
  • Phase 3 169 trials
  • Phase 4 39 trials
  • Not applicable 311 trials
  • Observational 166 trials
  • Expanded access 6 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 244 trials
  • Completed 583 trials
  • Terminated 150 trials
  • Other 20 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Unknown)

Top of scale: 73

1998: 3 trials (Observational 1, Phase 3 1, Phase 2 1) 2000: 2 trials (Observational 1, Phase 3 1) 2001: 1 trials (Phase 1 1) 2002: 8 trials (Observational 2, Not applicable 1, Phase 3 2, Phase 2 2, Phase 1 1) 2003: 8 trials (Observational 2, Not applicable 2, Phase 4 1, Phase 3 1, Phase 2 1, Phase 1/2 1) 2004: 9 trials (Observational 1, Phase 4 1, Phase 3 4, Phase 2 3) 2005: 21 trials (Observational 1, Not applicable 2, Phase 4 2, Phase 3 9, Phase 2/3 1, Phase 2 4, Phase 1 2) 2006: 18 trials (Observational 3, Not applicable 1, Phase 4 2, Phase 3 4, Phase 2 6, Phase 1 2) 2007: 24 trials (Observational 3, Not applicable 3, Phase 4 1, Phase 3 7, Phase 2/3 1, Phase 2 4, Phase 1/2 1, Phase 1 4) 2008: 25 trials (Observational 3, Not applicable 6, Phase 4 4, Phase 3 4, Phase 2/3 1, Phase 2 6, Phase 1/2 1) 2009: 27 trials (Observational 7, Not applicable 1, Phase 4 1, Phase 3 8, Phase 2/3 2, Phase 2 7, Phase 1 1) 2010: 27 trials (Observational 4, Not applicable 5, Phase 3 5, Phase 2 7, Phase 1/2 2, Phase 1 4) 2011: 37 trials (Observational 9, Not applicable 10, Phase 3 5, Phase 2 9, Phase 1/2 2, Phase 1 2) 2012: 40 trials (Observational 10, Not applicable 9, Phase 3 11, Phase 2 8, Phase 1/2 1, Phase 1 1) 2013: 31 trials (Observational 6, Not applicable 13, Phase 4 1, Phase 3 5, Phase 2 2, Phase 1/2 3, Phase 1 1) 2014: 33 trials (Observational 8, Not applicable 7, Phase 3 5, Phase 2/3 4, Phase 2 6, Phase 1/2 2, Phase 1 1) 2015: 37 trials (Observational 7, Not applicable 11, Phase 4 2, Phase 3 5, Phase 2 9, Phase 1/2 1, Phase 1 2) 2016: 42 trials (Observational 9, Not applicable 9, Phase 4 4, Phase 3 10, Phase 2 5, Phase 1/2 2, Phase 1 3) 2017: 58 trials (Observational 7, Not applicable 19, Phase 4 3, Phase 3 10, Phase 2 12, Phase 1/2 2, Phase 1 5) 2018: 50 trials (Observational 8, Not applicable 23, Phase 4 3, Phase 3 3, Phase 2 7, Phase 1/2 4, Phase 1 2) 2019: 65 trials (Observational 11, Not applicable 27, Phase 4 3, Phase 3 8, Phase 2 14, Phase 1 2) 2020: 67 trials (Observational 9, Not applicable 24, Phase 3 7, Phase 2 23, Phase 1/2 1, Phase 1 3) 2021: 63 trials (Other 1, Observational 10, Not applicable 30, Phase 3 11, Phase 2 7, Phase 1/2 3, Phase 1 1) 2022: 73 trials (Observational 12, Not applicable 25, Phase 4 2, Phase 3 8, Phase 2/3 3, Phase 2 17, Phase 1/2 5, Phase 1 1) 2023: 70 trials (Observational 9, Not applicable 34, Phase 4 3, Phase 3 9, Phase 2 7, Phase 1/2 2, Phase 1 6) 2024: 61 trials (Observational 9, Not applicable 20, Phase 4 1, Phase 3 9, Phase 2 10, Phase 1/2 6, Phase 1 6) 2025: 49 trials (Observational 8, Not applicable 13, Phase 4 3, Phase 3 11, Phase 2/3 3, Phase 2 6, Phase 1/2 1, Phase 1 4)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 39
2025 49
2024 61
2023 70
2022 73
2021 63
2020 67
2019 65
2018 50
2017 58

Showing 10 of 28 years.

Start your 14-day trial Email me all 28 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 997 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 241 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 497 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF